2026-525625-21-00
Recruiting
Phase 1
A clinical trial of MK-6050 in healthy participants (MK-6050-002)
ConditionsHidradenitis suppurativa
Overview
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Merck Sharp & Dohme LLC
- Enrollment
- 52
- Locations
- 2
Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Daniel Okin
Scientific
Merck Sharp & Dohme LLC
Study Sites (2)
Loading locations...
Similar Trials
Recruiting
Phase 1
A clinical study of MK-6050 in healthy people (MK-6050-001)2025-523861-58-00Merck Sharp & Dohme LLC32
Recruiting
Phase 1
A clinical trial of MK-6916 in healthy participants (MK-6916-010)2025-524570-41-00Merck Sharp & Dohme LLC54
Recruiting
Phase 1
A clinical study of MK-6916 in healthy people (MK-6916-006)2025-521487-36-00Merck Sharp & Dohme LLC40
Completed
Phase 1
A clinical study of MK-6916 and placebo in healthy people (MK-6916-003)2024-516878-30-00Merck Sharp & Dohme LLC16
Recruiting
Phase 1
A clinical study of MK-1289 in healthy adult men (MK-1289-001)2025-521395-63-00Merck Sharp & Dohme LLC28